Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v5-EN
Language French English
Date Updated 2021-04-20 2021-04-20
Drug Identification Number 02408538 02408538
Brand name CLINDAMYCIN IV INFUSION CLINDAMYCIN IV INFUSION
Common or Proper name CLINDAMYCIN IV INFUSION CLINDAMYCIN IV INFUSION
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients CLINDAMYCIN CLINDAMYCIN
Strength(s) 18MG 18MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 900MG/50ml 10 LIIF 900MG/50ml 10 LIIF
ATC code J01FF J01FF
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2021-04-01 2021-04-01
Estimated end date 2021-04-23 2021-04-23
Actual end date 2021-04-16 2021-04-16
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments